Advanced Search

CN 34-1304/RISSN 1674-3679

Volume 28 Issue 12
Dec.  2024
Turn off MathJax
Article Contents
WANG Ziwei, LI Ying, HUANG Zhuojun, GAO Meng, GONG Liping, LI Zeyang, XU Xuewei, DAI Seying, FAN Yinguang. Awareness and testing willingness of hepatitis C among people aged 50 and above in Anhui Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(12): 1420-1425. doi: 10.16462/j.cnki.zhjbkz.2024.12.009
Citation: WANG Ziwei, LI Ying, HUANG Zhuojun, GAO Meng, GONG Liping, LI Zeyang, XU Xuewei, DAI Seying, FAN Yinguang. Awareness and testing willingness of hepatitis C among people aged 50 and above in Anhui Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(12): 1420-1425. doi: 10.16462/j.cnki.zhjbkz.2024.12.009

Awareness and testing willingness of hepatitis C among people aged 50 and above in Anhui Province

doi: 10.16462/j.cnki.zhjbkz.2024.12.009
WANG Ziwei and LI Ying contributed equally to this work
Funds:

Research Funds of Center for Big Data and Population Health of IHM JKS2022003

Chinese Center for Disease Control and Prevention 2023-CG-Room of Hepatitis C and Sexually Transmitted Diseases Prevention and Control-028

Chuzhou Municipal Health Commission Research Project CZWJ2022B002

More Information
  • Corresponding author: DAI Seying, E-mail: fjptdsy@126.com; FAN Yinguang, E-mail: fanyinguang@163.com
  • Received Date: 2024-08-04
  • Rev Recd Date: 2024-11-18
  • Available Online: 2025-01-24
  • Publish Date: 2024-12-10
  •   Objective  To understand the awareness of hepatitis C prevention and treatment and willingness to be tested among people aged 50 and above, and analyzing factors influencing their willingness to undergo hepatitis C testing, in order to provide a reference for hepatitis C prevention and treatment work.  Methods  A multistage sampling method was used to select people aged 50 years and above between January and July 2023 in Hefei City, Chuzhou City and Bozhou City, Anhui Province. Information on demographic characteristics, awareness of hepatitis C prevention and treatment, and willingness to be tested for hepatitis C was collected from the survey respondents. Chi-quare test was used to compare the differences in the willingness to test for hepatitis C among people aged 50 and above with different characteristics, and binary logistic regression analysis was used to analyze the relevant factors affecting the willingness to test for hepatitis C among people aged 50 and above in Anhui Province.  Results  Among the 6 857 participants, males accounted for 51.7%, with an average age of (69.97±9.02) years. The overall awareness rate regarding hepatitis C prevention and treatment was 21.6%. The self-reported past hepatitis C testing rate among the participants was 10.2%, and 79.4% expressed willingness to undergo hepatitis C testing in the next three months. Additionally, 79.4% of the participants expressed willingness to undergo hepatitis C testing in the next three months. The results of the multivariate analysis showed that females (OR=0.811, 95% CI: 0.709-0.928, P=0.002), married/cohabiting (OR=0.362, 95% CI: 0.247-0.531, P < 0.001) and separated/divorced/widowed (OR=0.614, 95% CI: 0.416-0.904, P=0.014), middle school (OR=0.671, 95% CI: 0.570-0.790, P < 0.001), individual monthly income of 3 000-5 000 (OR=0.522, 95% CI: 0.440-0.618, P < 0.001) and ≥5 000 (OR=0.502, 95% CI: 0.365-0.690, P < 0.001) had lower willingness to be tested for hepatitis C; while cohabitation with parents / children / spouses / sexual partners (OR=4.686, 95% CI: 3.739-5.874, P < 0.001) and pension institutions (OR=3.203, 95% CI: 2.276-4.507, P < 0.001), having had a HIV test (OR=2.872, 95% CI: 2.434-3.389, P < 0.001), and high-risk groups (OR=2.220, 95% CI: 1.930-2.554, P < 0.001) had a higher willingness to be tested for hepatitis C.  Conclusions  Currently, the cyclic patterns of AIDS incidence and mortality in China have reached their historical peak, with cycles becoming notably longer. Predictions indicate a future downward trend in both incidence and mortality, so we should pay close attention to the epidemic situation of AIDS, and actively take preventive and control measures.
  • loading
  • [1]
    Liu CH, Chang YP, Kao JH. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review[J]. Expert Opin Pharmacother, 2024, 25(12): 1691-1706. DOI: 10.1080/14656566.2024.2396024.
    [2]
    Vo TD, Bui VTT, Lam HT, et al. High efficacy and safety of direct-acting antivirals for the treatment of chronic hepatitis C: a cohort study conducted in Vietnam[J]. Pharmacol Res Perspect, 2024, 12(5): e70007. DOI: 10.1002/prp2.70007.
    [3]
    World Health Organization. Hepatitis C[EB/OL]. (2024-04-09)[2024-08-02]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
    [4]
    World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis[EB/OL]. (2016-06-01)[2024-08-02]. https://www.who.int/publications/i/item/WHO-HIV-2016.06.
    [5]
    Zhou H, Yan MX, Che DT, et al. Universal screening for HCV infection in China: an effectiveness and cost-effectiveness analysis[J]. JHEP Rep, 2024, 6(4): 101000. DOI: 10.1016/j.jhepr.2024.101000.
    [6]
    Zhao ZY, Chu MJ, Guo YC, et al. Feasibility of hepatitis C elimination in China: from epidemiology, natural history, and intervention perspectives[J]. Front Microbiol, 2022, 13: 884598. DOI: 10.3389/fmicb.2022.884598.
    [7]
    Abu-Dayyeh I, Chemaitelly H, Ghunaim M, et al. Patterns and trends of hepatitis C virus infection in Jordan: an observational study[J]. Front Public Health, 2023, 11: 1280427. DOI: 10.3389/fpubh.2023.1280427.
    [8]
    Torre P, Coppola R, Masarone M, et al. Country-wide HCV elimination strategies need to each older patients in the general population: the Italian experience[J]. Viruses, 2023, 15(11): 2199. DOI: 10.3390/v15112199.
    [9]
    CDA Foundation. Mainland[EB/OL]. (2024-05-16)[2024-08-02]. https://cdafound.org/polaris-countries-database/.
    [10]
    Sallam M, Khalil R. Contemporary insights into hepatitis C virus: a comprehensive review[J]. Microorganisms, 2024, 12(6): 1035. DOI: 10.3390/microorganisms12061035.
    [11]
    戴色莺, 程晓莉, 吴建军, 等. 安徽省部分地区医院就诊人群丙型病毒性肝炎感染状况调查[J]. 中华疾病控制杂志, 2023, 27(7): 864-868. DOI: 10.16462/j.cnki.zhjbkz.2023.07.021.

    Dai SY, Cheng XL, Wu JJ, et al. Survey on hepatitis C infection among hospital patients in some counties and districts of Anhui Province[J]. Chin J Dis Control Prev, 2023, 27(7): 864-868. DOI: 10.16462/j.cnki.zhjbkz.2023.07.021.
    [12]
    李芳萍. 社区居民对乙肝、丙肝的认知现状及流行病学调查研究[D]. 广州: 广州医科大学, 2022.

    Li FP. The current situation of community residents' cognition and epidemiological investigation on hepatitis B and C[D]. Guangzhou: Guangzhou Medical University, 2022.
    [13]
    Liu Y, Su J, Wang XY, et al. Hepatitis C knowledge and self-reported testing behavior in the general population in China: online cross-sectional survey[J]. JMIR Public Health Surveill, 2023, 9: e39472. DOI: 10.2196/39472.
    [14]
    汤杨. 男性同性性行为人群的丙型肝炎认知及检测意愿研究[D]. 北京: 中国疾病预防控制中心, 2021.

    Tang Y. Study on hepatitis C awareness and willingness to test among men who have sex with men[D]. Beijing: Chinese Center for Disease Control and Prevention, 2021.
    [15]
    李娜, 范吉祥, 邱柏红, 等. 吉林省大众人群丙肝防治知识知晓率及其影响因素研究[J]. 实用预防医学, 2023, 30(10): 1257-1259. DOI: 10.3969/j.issn.1006-3110.2023.10.025.

    Li N, Fan JX, Qiu BH, et al. Study on the awareness rate of hepatitis C prevention and control knowledge and its influencing factors among the general population in Jilin Province[J]. Pract Prev Med, 2023, 30(10): 1257-1259. DOI: 10.3969/j.issn.1006-3110.2023.10.025.
    [16]
    Liu Y, Su J, Wang XY, et al. Hepatitis C knowledge and self-reported testing behavior in the general population in China: online cross-sectional survey[J]. JMIR Public Health Surveill, 2023, 9: e39472. DOI: 10.2196/39472.
    [17]
    胡灵利, 张丽春, 张志红, 等. 山西省某市社区老年居民丙型肝炎抗体筛查及认知率调查[J]. 山西医药杂志, 2022, 51(21): 2422-2425. DOI: 10.3969/j.issn.0253-9926.2022.21.006.

    Hu LL, Zhang LC, Zhang ZH, et al. Investigation on screening of hepatitis C antibody and awareness rate of elderly residents in a community of a city in Shanxi Province[J]. Shanxi Med J, 2022, 51(21): 2422-2425. DOI: 10.3969/j.issn.0253-9926.2022.21.006.
    [18]
    胡灵利. 社区老年居民丙型肝炎抗体筛查及认知率调查[D]. 太原: 山西医科大学, 2023.

    Hu LL. Investigation on screening of hepatitis C antibody and awareness rate among elderly residents in community[D]. Taiyuan: Shanxi Medical University, 2023.
    [19]
    Choi GH, Jang ES, Kim JW, et al. A survey of the knowledge of and testing rate for hepatitis C in the general population in South Korea[J]. Gut Liver, 2020, 14(6): 808-816. DOI: 10.5009/gnl19296.
    [20]
    廖龙玉, 林志峰, 王菲菲, 等. 广西南宁市某农村地区老年人群艾滋病知晓和HIV检测情况及其影响因素[J]. 中国健康教育, 2023, 39(9): 832-838. DOI: 10.16168/j.cnki.issn.1002-9982.2023.09.011.

    Liao LY, Lin ZF, Wang FF, et al. AIDS awareness and HIV testing of elderly population in a rural area of Nanning City and their influencing factors[J]. Chinese Journal of Health Education, 2023, 39(9): 832-838. DOI: 10.16168/j.cnki.issn.1002-9982.2023.09.011.
    [21]
    Alzahrani MS, Ayn Aldeen A, Almalki RS, et al. Knowledge of and testing rate for hepatitis C infection among the general public of Saudi Arabia: a cross-sectional study[J]. Int J Environ Res Public Health, 2023, 20(3): 2080. DOI: 10.3390/ijerph20032080.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (25) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return